Background
==========

CAV is a small non-enveloped, single-stranded, circular DNA virus and was first isolated in Japan \[[@B1]\]. This virus belongs to the genus Gyrovirus of the Circoviridae family and causes a severe immunosuppressive syndrome and anemia in chickens \[[@B2]\]. It is a ubiquitous pathogen of chickens and has a worldwide distribution. According to epidemiological studies, it has been shown that almost all newly hatched chicks are susceptible to CAV as a clinical syndrome, but not mature chickens \[[@B3]\]. Normally, young chickens, generally fewer than 2 weeks of age, are very susceptible to this virus through vertical transmission via hatching eggs \[[@B4]\]. The virus typically induces aplasia of the bone marrow and damage to lymphoid tissue, which causes anemia and acute immunodeficiency syndrome \[[@B5],[@B6]\]. Up to the present, a large number of isolates, including strains from Australia, Bangladesh, Brazil, China, Germany, Malaysia, Nigeria, Slovenia, Taiwan and USA, have been reported and have had full or partial sequences published \[[@B7]-[@B9]\].

The DNA genome of CAV is about 2.3 kb in size \[[@B10]-[@B12]\] and there are three ORFs present on the negative sense genome. At least three proteins are produced from a single polycistronic 2.1 kb mRNA that is reliable produced as a single molecule and contains a promoter, TATA-box, and poly (A) signal \[[@B11],[@B13],[@B14]\]. The three translated proteins are called VP1, VP2 and VP3. VP1 is a 51 kDa protein that is the structure protein involved in assembly of the viral caspid \[[@B15]\]. VP2 is a 24 kDa protein that contains a dual-specificity phosphatase (DSP) activity and some apoptotic activity \[[@B2],[@B16],[@B17]\]. However, VP2\'s apoptotic activity is much weaker than that of VP3. VP3 is a 13 kDa protein, also named apoptin, which induces apoptosis in infected chicken cells and human tumor cell lines \[[@B2],[@B18],[@B19]\]. During virus infection, VP2 and VP3 are detected very early, namely 12 h post infection, while VP1 is detected only after 30 h post infection \[[@B16]\]. Some additional proteins have been reported to be translated after further splicing of the mRNA, but their biological functions have not been elucidated \[[@B20]\].

As mention above, VP2 is a DSP enzyme \[[@B17]\]. The key catalytic residues of active site have been identified to be serine, threonine, and tyrosine. The cysteine residues, respectively, are located at positions 95 and 97 in the catalytic motif of VP2. Furthermore, mutation of these residues to serine results in reduced virus replication efficiency in the cell \[[@B17]\]. This effect indicates that the phosphatase activity of VP2 is required for virus replication. It has been reported that co-expression of VP1 and VP2 allows neutralizing antibodies to be raised \[[@B21],[@B22]\] and it has been suggested that VP2 is a scaffold protein \[[@B23]\] that corrects the conformation of VP1. Therefore, it is expected that VP2 is a multifunctional protein with roles in virus infection, assembly and replication. VP2 possess a putative NLS and the protein is known to accumulate to a large extent in the nucleus of infected chicken cells \[[@B16],[@B24]\]. A recent study has shown that VP2, when fused to GFP, shows nuclear localization and this result indicates that the NLS of VP2 is also functional in plants \[[@B25]\].

Until now, the specific mechanism for the cellular localization of VP2 is not well understood. In this study, we first use bioinformatics to analysis the amino acid sequence of various different isolates of VP2, and were able to predict and examine for the presence of putative NLS and NES motifs, which have never been characterized previously. We generated GFP fused to various versions of VP2 created by truncation, site directed mutagenesis, and multiple site directed mutagenesis in order to confirm the locations of these putative NLS and NES sequences. Leptomycin B (LMB) can be used to identify the presence of a NES motif in a protein because it inhibits the CRM1 pathway and such a result has been found for VP3 of CAV. Using LMB, our results suggest that VP2 does not contain a functional NES and also that VP2 is CRM1 independent. Additionally, using a co-immunoprecipitation assay, we also found that VP2 associates with MCM3 and that this interaction does not require DSP activity.

Results
=======

Localization of VP2 in mammalian cells
--------------------------------------

In previous studies, it has been shown by indirect immunoperoxidase staining that VP2 is localized within the nuclei of MDCC-MSB 1 cells infected with CAV \[[@B16]\]. In 2007, Lacorte et al. reported that transient expression of GFP-VP2 could be observed throughout the nucleoplasm in plant cells \[[@B25]\]. In the present study, we constructed expression plasmids of VP2-GFP in order to identify the nuclear localizing characteristics in cells. After transient transfection, the bright fluorescence of VP2-GFP was observed mostly in the nucleus of both HeLa and CHO cells. In contrast, when GFP alone was introduced, not only the nucleus but also the cytoplasm was fluorescent. This indicates that a functional NLS was present in VP2 as suggested by previously (Figure [1A](#F1){ref-type="fig"} and [1B](#F1){ref-type="fig"}).

![**VP2 protein is localized to the nucleus of the mammalian cells**. HeLa (**A**) and CHO (**B**) cells both were transfected with GFP and VP2-GFP expressing plasmids (green). At 48 h post-transfection, the cells were fixed and stained with DAPI (blue). The distribution of GFP and VP2-GFP in the cells were followed by microscopy (phase) and fluorescence microscopy](1746-6148-8-15-1){#F1}

Using bioinformatics to predict the NLS and NES containing regions
------------------------------------------------------------------

In order to identify if there are any NLS or NES motifs in VP2, we first compared the amino acid sequence of VP2 (Taiwan CIA-89) with a range of other CAV isolates to explore the protein\'s sequence divergence. The various VP2 sequences of the different CAV isolates were obtained from the UniProtKB database (<http://www.uniprot.org/>). Based on the sequence alignment, the VP2 proteins of these CAV isolates are highly conserved compared to strain CIA-89 from Taiwan. Therefore, the full length of amino acid sequence of VP2 (Taiwan CIA-89) was used and examined in order to predict NLS sequences using the WoLF PSORT and NLStradamus programs (Figures [2](#F2){ref-type="fig"} and [3A](#F3){ref-type="fig"}). A bipartite NLS motif (named BiNLS1) was predicted by the WoLF PSORT program, with the putative motif position spanned amino acid residues from 136 to 153 (under line). However, a monopartite NLS motif (named NLS2) was also predicted by NLStradamus at a prediction cutoff value at 0.5 and this motif was located from amino acid residues from 133 to 138 (bold). Based on the results of bioinformatics analysis, VP2 was predicted to containing two possible NLS motifs. In addition, the NES motif prediction was performed by NetNES 1.1 Server (Figures [2](#F2){ref-type="fig"} and [3A](#F3){ref-type="fig"}). A putative NES from amino acid residues 120 to 128 (under line, bold, shadow and Italic) was pinpointed. However, the expected value for NES prediction was lower than threshold expected value of this program, which suggests that there is a low probability of a NES motif existing within VP2. Based on these results, further investigations were needed to elucidate whether or not a NES is functional in VP2.

![**Analysis and predication of NLS and NES motifs present in the VP2 amino acid sequence**. The various VP2 amino acid sequences (51 to 200) from different CAV isolates were aligned as described in the Materials and Methods. The putative NLS motifs (BiNLS1: under line and NLS2: bold words) and NES motifs (under line, bold, shadow and Italic) are shown. The cysteine residues at positions 95 and 97 in the catalytic motif of VP2 are also indicated by an arrow and an arrow head, respectively](1746-6148-8-15-2){#F2}

![**Mutant constructs of VP2-GFP that were used in this study**. (**A**) Truncated fragments of the VP2 (black bars) encoding constructs fused with GFP (white bars) were used in this study. The right panels indicate the localization patterns in cells. GFP distribution in the cytosol is indicated by C; GFP signal in nucleus that is stronger than that in the cytosol is indicated by N; GFP detected in both the cytosol and nucleus is indicated by N/C. The putative NLS motifs (BiNLS1 and NLS2) and the weak NES motif are shown. The amino acids present in the constructs are also indicated. (**B**) Subcellular localization of C-terminal deleted VP2-GFP constructs (115dC, 132dC and 145dC) in HeLa and CHO cells (green). (**C**) Subcellular localization of N-terminal deleted VP2-GFP constructs (111dN, 141dN and 160dN) in HeLa and CHO cells (green). All cells were fixed and stained with DAPI (blue)](1746-6148-8-15-3){#F3}

Identification of BiNLS1 function in VP2
----------------------------------------

As mentioned above, two putative NLS motifs, a bipartite BiNLS1 and a monopartite NLS2 were predicted to be present in VP2. To determine the exactly site of the NLS motif in VP2, we constructed a full length clone and six deletion clones of VP2 fused with GFP at the C-terminus (Figure [3A](#F3){ref-type="fig"}). The subcellular locations of these expressed constructs in the transfected cells based on the GFP distribution pattern at 48 h post-transfection were examined. The truncated C-terminal deletion of VP2-GFP fusion proteins were VP2 115dC, VP2 132dC, and VP2 145dC. The N-terminal deletion mutants were VP2 111dN, VP2 141dN, and VP2 160dN. In Figure [3B](#F3){ref-type="fig"}, two of the C-terminal deletions, VP2 115dC, and VP2 132dC showed fluorescence distributed in both the nucleus and cytoplasm of HeLa cells (Figure [3B](#F3){ref-type="fig"}), whereas the bright fluorescence of these two truncations was predominantly distributed in the cytoplasm of CHO cells (Figure [3B](#F3){ref-type="fig"}). Fluorescence due to VP2 145dC was localized in the nucleus of both HeLa and CHO cells (Figure [3B](#F3){ref-type="fig"}). Furthermore, VP2 111dN was also localized to the nucleus of HeLa and CHO cells (Figure [3C](#F3){ref-type="fig"}). In contrast, fluorescence by VP2 141dN and VP2 160dN was found to have a very similar pattern to that of GFP in both the nucleus and cytoplasm of HeLa and CHO cells (Figure [3C](#F3){ref-type="fig"}).

On comparing the fluorescence distribution patterns of VP2 111dN and VP2 141dN in mammalian cells, we found that the C-terminus part of BiNLS1 from VP2 did not seem to contain a nuclear import function. To support this finding, we used site directed mutagenesis to create a series of BiNLS1 mutants, namely VP2 150-152A (R150A, K151A and K152A), VP2 136-138A (K136A, R137A, and K138A) and VP2 136-138A/150-152A, as shown in Table [1](#T1){ref-type="table"}. All of these mutants were able to express and were localized to the nucleus of HeLa and CHO cells (Figure [4A](#F4){ref-type="fig"}). The results indicated that NLS motif did not include the whole putative region of BiNLS1 as predicted by bioinformatics.

###### 

Intracellular localization of VP2 and various mutants of the NLS motif

  Name of mutants          Localization^a^   NLS motifs of amino acids sequence^b,\ c^
  ------------------------ ----------------- --------------------------------------------------------------------------------------------------------------------------------------------
  VP2-GFP                  N                 **K^133^R^134^A^135^[K^136^R^137^K^138^]{.ul}**[L^139^D^140^Y^141^H^142^Y^143^S^144^Q^145^P^146^T^147^P^148^N^149^R^150^K^151^K^152^]{.ul}
                                             
  VP2 150-152A             N                 **K^133^R^134^A^135^[K^136^R^137^K^138^]{.ul}**[L^139^D^140^Y^141^H^142^Y^143^S^144^Q^145^P^146^T^147^P^148^N^149^A^150^A^151^A^152^]{.ul}
                                             
  VP2 136-138A             N                 **K^133^R^134^A^135^[A^136^A^137^A^138^]{.ul}**[L^139^D^140^Y^141^H^142^Y^143^S^144^Q^145^P^146^T^147^P^148^N^149^R^150^K^151^K^152^]{.ul}
                                             
  VP2 136-138A/150-152A    N                 **K^133^R^134^A^135^[A^136^A^137^A^138^]{.ul}**[L^139^D^140^Y^141^H^142^Y^143^S^144^Q^145^P^146^T^147^P^148^N^149^A^150^A^151^A^152^]{.ul}
                                             
  VP2 136-138A/133A        C                 **A^133^R^134^A^135^A^136^A^137^A^138^**
                                             
  VP2 136-138A/134A        C                 **K^133^A^134^A^135^A^136^A^137^A^138^**
                                             
  VP2 136-138A/133A/134A   C                 **A^133^A^134^A^135^A^136^A^137^A^138^**
                                             
  VP2 133A                 N                 **A^133^R^134^A^135^K^136^R^137^K^138^**
                                             
  VP2 134A                 N                 **K^133^A^134^A^135^K^136^R^137^K^138^**
                                             
  VP2 133A/134A            N                 **A^133^A^134^A^135^K^136^R^137^K^138^**

a\. The N and C indicate nuclear and cytoplasm, respectively.

b\. The BiNLS1 and NLS2 motifs are indicated by underlining and bold, respectively.

c\. The amino acids of BiNLS1 are shown from K136 to K152 and of NLS2 are shown from K133 to K138.

![**Identification of the NLS motifs (BiNLS1 and NLS2) in VP2**. (**A**) Substitutive mutagenesis was used to create three constructs, VP2 150-152 (RKK to AAA), VP2 136-138 (KRK to AAA), as well as double and triple mutations, within the BiNLS1 region of VP2 (also saw in Table 1). The subcellular localization of these mutants (green) were examined by fluorescent microscopy in HeLa and CHO cells. (**B**) To further identify the functional NLS motif, K133 and R134 were replaced by alanine. The mutants (VP2 136-138A/134A, VP2 136-138A/133A and VP2 136-138A/133A/134A) were then expressed and examined by fluorescent microscopy (green). All cells were fixed and stained with DAPI (blue). (**C**) Identification of NLS2 in VP2. The point mutations VP2 133A, VP2 134A and VP2 133A/134A were transfected into HeLa cells. After 48 h post-transfection, the distributions of GFPs (green) were monitored by fluorescence microscopy. The cells were fixed and stained with DAPI (blue)](1746-6148-8-15-4){#F4}

The nuclear localization signal is within the NLS2 motif of VP2
---------------------------------------------------------------

Next, we focused on NLS2 motif in order to characterize the NLS motif within VP2. The VP2 132dC mutant produced fluorescence that was distributed across both the nucleus and cytoplasm of HeLa cells and in the cytoplasm of CHO cells. In contrast, the fluorescence produced by VP2 145dC was localized to the nucleus of HeLa and CHO cells. These results indicate that NLS motif of VP2 would seem to span amino acid residues 132 to 144. This region contains the NLS2 motif, which covers amino acid residues 133 to 138. We changed the positive charge of amino acids from 136 to 138 residues to alanine and measured the distribution of GFP. We found that the nuclear localization of GFP fluorescence of the VP2 136-138A mutants within this region was not abolished. However, our results indicated the presence of critical amino acid residues within the NLS motif of VP2 that play an essential role in nuclear transport. Specifically, alanine substitution mutagenesis at positions K133A and R134A of VP2 and of the VP2 136-138A clone was carried out to further characterize the nuclear localization motif and the results were summarized in Table [1](#T1){ref-type="table"}. These results were shown that nuclear transportation of VP2 was obviously disrupted in three alanine substitution constructs, namely VP2 136-138A/133A, VP2 136-138A/134A, and VP2 136-138A/133A/134A (Figure [4B](#F4){ref-type="fig"}) but not in VP2 133A, VP2 134A and VP2 133A/134A (Figure [4C](#F4){ref-type="fig"}). The GFP signal distributions of VP2-GFP and its mutants in CHO cells are shown in Figures [1B](#F1){ref-type="fig"} and [4B](#F4){ref-type="fig"} and these were analyzed quantitatively by using Alpha View^®^Software (Figure [5](#F5){ref-type="fig"}). VP2-GFP was 94% of the time in nucleus and 6% in cytosol. The nuclear presence of the VP2 136-138A/133A, VP2 136-138A/134A, and VP2 136-138A/133A/134A mutant was reduced to 13%, 12% and 11%, respectively, with most of GFP signal accumulated in the cytoplasm. These findings demonstrate that NLS2 is a functional NLS motif in VP2 and that amino acid residues K133 and R134 are also important to this functionality (Figures [4B](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}).

![**The distribution of VP2-GFP and mutants in cytoplasm and nucleus of cells**. VP2-GFP and various mutants (VP2 136-138A/134A, VP2 136-138A/133A and VP2 136-138A/133A/134A) were transfected into CHO cells. After 48 h transfection, all cells were fixed and stained with DAPI. The distribution of GFP was monitored by fluorescence microscopy. In VP2-GFP and mutants, twenty cells were measured the distribution of GFP signals from cytoplasm and nucleus using Alpha View^®^Software (Alpha Innotech Corporation)](1746-6148-8-15-5){#F5}

VP2 is a CRM1 independent protein
---------------------------------

Typical NES motifs have been found in the various viral and cellular proteins and are involved in transportation between the nucleus and the cytoplasm \[[@B26]\]. LMB has been shown to interfere with the CRM1-NES interaction and can be used to verify the functionality of any NES motif. A weak putative NES motif spanning amino acid residues from 120 to 128 of VP2 was predicted earlier (Figure [2](#F2){ref-type="fig"}). However, the prediction score was lower than the program threshold. The weak putative NES motif was investigated using the truncated mutants shown in Figure [3A](#F3){ref-type="fig"} together with LMB (+) (20 ng/ml) and LMB (-) (PBS) buffers, which were added to cells at 48 h post-transfection and incubated for 1 h \[[@B27],[@B28]\]. VP3-GFP was used as a positive control because it has been reported to be a CRM1 dependent protein and contains a NES motif \[[@B29],[@B30]\]. The distribution of fluorescence was then observed (see Additional file [1](#S1){ref-type="supplementary-material"}) and the results demonstrated that, while LMB was able to affect the nuclear export of VP3, it had no effect on VP2. Therefore it would seem that VP2 nuclear export is a CRM1 independent process and that there is no functional NES motif present in VP2.

VP2 binds to chromatin
----------------------

As previously reported and confirmed by this study, VP2-GFP predominantly is localized in nucleus (Figure [1](#F1){ref-type="fig"}). In order to further investigate this localization, CHO cells were transfected with VP2-GFP plasmid and the resulting cell extract separated into soluble and chromatin fractions. As is shown in Figure [6A](#F6){ref-type="fig"}, VP2-GFP could be detected in both the soluble and chromatin fractions. The chromatin fraction was further digested with micrococcal nuclease (MNase). Like MCM3, VP2-GFP was only partial dissociated from the chromatin fraction after treatment with MNase, which suggested that VP2 is a chromatin-bound protein and MNase-resistant. The chromatin fraction was also treated with different concentration of NaCl. The result is shown in Figure [6A](#F6){ref-type="fig"}, whereby VP2-GFP was found to be slightly dissociation at 0.3 M NaCl and 0.5 M NaCl, but a significant amount of remaining protein remained bound to the chromatin. When tested under similar conditions, the lamin B receptor, a nuclear matrix protein, was not extracted by 0.3 M NaCl and 0.5 M NaCl. Therefore, these results strongly suggest that VP2, like MCM3, is a chromatin binding protein, but was not a nuclear matrix protein.

![**VP2 binds to chromatin and interacts with MCM3 but this does not require dual phosphatase activity**. (**A**) The soluble (S) and chromatin (C) fractions were prepared by using CSK buffer containing 0.5% Triton X-100 in CHO cells of transfected with VP2-GFP plasmid. The fractions were treated with 0 U (-) and 150 U (+) of MNase or the indicated concentrations of NaCl. Nuclear extracts (N) containing VP2-GFP were as positive control and all fractions were subjected to immunoblotting against with lamin B receptor, MCM3, and VP2 antibodies. (**B**) At 48 h post-transfection, the GFP (as Control) and Flag-VP2-GFP (as wild-type; WT) were found in the CHO cells. Next the lysates were immunoprecipitated using Flag M2 beads and immunoblotted against VP2 and MCM3 antibodies. (**C**) The WT and mutants (C95S, C97S, and C95S/C97S) of the Flag-VP2-GFP in CHO cells were also examined at 48 h post-transfection. The cell lysates were immunoprecipitated using Flag M2 beads and immunoblotted against with VP2 and MCM3 antibodies. The arrow head was indicated a none-specific band. The nuclear extracts containing VP2-GFP were designated as N](1746-6148-8-15-6){#F6}

The DSP activity of VP2 is not required for protein-protein interaction with MCM3
---------------------------------------------------------------------------------

In a previous study, the DSP activity of VP2 was shown to be needed for virus replication in the cell \[[@B28]\]. In order to address what proteins in the various DNA replication complexes interacts with VP2 in cells, an independent assay involving immunoprecipitation using anti-Flag M2 beads against Flag-VP2-GFP was employed. In the control experiments, GFP expressing plasmids were transfected into cells and it was found that no none-specific proteins were brought down by the Flag M2 beads using Western blot detection (Figure [6B](#F6){ref-type="fig"}, lane Control). On the other hand, Flag-VP2-GFP was co-immunoprecipited with MCM3 protein by the Flag M2 beads (Figure [6B](#F6){ref-type="fig"}, lane WT) when compared to the protein band in the Flag-VP2-GFP nuclear extract (Figure [6B](#F6){ref-type="fig"}, lane N). In contrast, other components of DNA replication complexes such as CDC7, PCNA and condensin SMC2, as well as the core histones such as H2B, were not co-immunoprecipited with VP2 using CHO cell extracts (see Additional file [2](#S2){ref-type="supplementary-material"}). The above results confirmed that VP2 associates with MCM3 when it binds to chromatin.

To identify whether the dual phosphatase activity of VP2 was needed for association with MCM3, we performed a site directed mutagenesis assay targeting position C95 and C97 of VP2 in order to create the single mutants C95S and C97S and the double mutant C95S/C97S, which have either partial or complete disruption of the DSP activity associated with VP2 \[[@B17]\]. Co-immunoprecipitation assays were carried out and, the results are shown in Figure [6C](#F6){ref-type="fig"}, MCM3 was co-immunoprecipitated by the three mutants of VP2 protein in a similar manner to the wild type protein, which shows that VP2 binding to MCM3 does not require dual-phosphatase activity (Figure [6C](#F6){ref-type="fig"}).

Discussion
==========

CAV is an important avian pathogen worldwide and causes major economic damage throughout the poultry industry. Three major proteins are encoded by this virus, namely the capsid protein VP1, the nonstructural protein VP2, and the apoptin VP3. However, up to the present, the exactly functions of these three proteins in cell are still poorly understood. In previous studies, the expression of VP2 was found to be nuclear in plant cells \[[@B25]\]. This result is similar to that of the present study, where, VP2 was found to accumulate in the nucleus of both HeLa and CHO cells. Our results, both by bioinformatics and site-directed mutagenesis, support the hypothesis that VP2 contain a NLS and named as NSL2. NLS2 was shown to be a functional NLS that allowed transfer of VP2 into nucleus. This is similar to VP3, which has two functional NLS motifs that are also used for nuclear localization. The single VP2 NLS motif spans amino acid residues 133 to 138. Within this motif, we also found that two amino acids with positive charges, 133R and 134 K were important to allowing VP2 protein to shuttle from the cytoplasm to the nucleus. To the best of our knowledge, this is the first report identifying a NLS motif in the VP2 of CAV.

Subsequent sequence analysis showed that VP2 might contain a putative CRM1-mediated NES motif that stretched from amino acid 120 to amino acid 128, however the scores for this motif was below the program threshold. In order to confirm that a NES motif really existed in VP2, we used fusion protein constructs to investigate nuclear transportation in the presence of LMB assay (Figures [3A](#F3){ref-type="fig"} and see Additional file [1](#S1){ref-type="supplementary-material"}). A control protein, namely VP3, also named apoptin, which contains a classical leucine-rich NES motif and has been previously described as sensitive to LMB treatment was included in the study \[[@B29],[@B30]\]. Our results confirmed that the cytoplasm and nuclear distribution of the various truncated VP2 mutants was not obviously changed in pattern after treatment with LMB. This supports two possibilities; firstly, that the nuclear export pathway (using NES motif) of VP2 might not exist and/or, secondly, that a distinct and CRM1 dependent pathway was adopted by VP2 for nuclear export.

VP2 has been shown to contain dual phosphatase activity and this activity is required for CAV replication \[[@B17],[@B31]\]. However, in this context, very little is known about the role this protein plays in the regulation of viral DNA replication. When cells are infected with CAV, VP2 is expressed and accumulates, reaching a detectable level at 12 h post-infection \[[@B8],[@B16]\]. In contrast, VP1 has been found to accumulate to a higher level at 30 h post-infection. Amino acids sequence analysis of CAV VP1 was revealed that the N-terminal region show similarity to protamines \[[@B11]\], this supports the hypothesis that VP1 has DNA-binding functionality \[[@B32]\]. The N and C-terminal domains of VP3 separately bind to DNA and indicating the presence of multiple independent binding sites \[[@B33]\]. However, VP2 protein has no obvious DNA binding characteristics. In this study, VP2 of CAV is shown to be localized to the nucleus in two cell lines (Figure [1](#F1){ref-type="fig"}) and also to bind to chromatin (Figure [6](#F6){ref-type="fig"}). The latter finding was confirmed by examining the nuclease-resistant fraction and by treating with high salt. VP2 is similar to MCM3, a component of various MCM2-7 complexes, and other nuclease-resistant chromatin bound proteins such as CDC6 \[[@B18]\], minichromosome maintenance proteins (MCMs) \[[@B34]\], and PCNA \[[@B35]\], all of which have chromatin-bound characteristics. This suggests that the early expression of VP2 might involve DNA replication with VP2 interacting with the prereplication complex (Figure [6B](#F6){ref-type="fig"}). The association of VP2 with MCM3 (and perhaps other members of a MCM2-7 complex) may facilitate the DNA replication of CAV. However, it is still unknown whether VP2 is able to bind to DNA directly and this will need further investigation. Moreover, VP2\'s association with MCM3 does not require dual phosphatase activity (Figure [6C](#F6){ref-type="fig"}) and therefore, the relevance of VP2\'s DSP activity to the live cycle of CAV also needs further investigation.

Rep, a viral protein with replicase activity involved in regulating rolling-circle replication (RCR), has been found in most circovirus members of the family Circoviridae \[[@B36]\]. CAV seems to lack a Rep protein. However, some studies have proposed that the C-terminus of CAV VP1 contains a highly conserved RCR motif and that this may play a role in regulating the RCR reaction \[[@B32]\]. This RCR-regulating function of VP1 seems to be very similar to that of the Rep protein. Therefore, VP1 may interact with VP2 to form a nucleoprotein complex and, in addition, the genomic DNA of the virus might also be coupled with VP1 and VP2 in order to regulate the RCR reaction during the early stages of infection. However, these hypotheses need to be investigated in terms of how the MCMs interact with the VP2 of CAV.

Conclusions
===========

We have demonstrated that the VP2 of CAV contains a functional NLS motif that spans amino acids 133 to 138 of the protein. In addition to having a NLS, VP2 is also a chromatin binding protein similar to members of the MCM2-7 complex. Moreover, VP2 associates with MCM3 in cells based on co-immunoprecipitation analysis. Taken together, these findings suggest that VP2 may be part of a DNA pre-replication complex.

Methods
=======

Antibodies
----------

All primary anti-human and mouse antibodies used for immunoblotting were purchased from commercial companies. Rabbit polyclonal anti-human and mouse antibodies were obtained as follows: SMC2, CDC7, and H2B from Santa Cruz Biotechology, USA; MCM3 from Bethyl Laboratories, USA; PCNA from Epitomics, USA and rabbit monoclonal anti-human and mouse lamin B receptor antibody from Abcam, USA. The anti-VP2 of CAV polyclonal antibody was prepared by immunizing rabbits using VP2 of CAV expressed in *E. coli*\[[@B37]\]. The secondary antibodies for Western blotting were as follows: the goat anti-mouse IgG and goat anti-rabbit IgG conjugated HRP, which were both obtained from Santa Cruz Biotechology, USA.

Construction of plasmids
------------------------

Various plasmids, such as pcDNA3.1 VP2-GFP, pcDNA3.1 Flag-VP2-GFP and pcAcGFP1-N1 VP3-GFP, were constructed as described below. The full-length of VP2, Flag-VP2 and VP3 were amplified by PCR using high fidelity Platinum Taq DNA polymerase (Invitrogen, USA) from pGEX-6P-1-VP2 \[[@B38]\] and pGEX-6P-1-VP3 (data not shown) using the primers: forward VP2 1-18 EcoRI 5\' TGGAATTCATGCACGGGAACGGCGGA3\' or VP2 Flag EcoRI 5\' AGGATCCATGGATTACAAGGATGACGACGATAAGGAATTCATGCACGGGAACGGCGGACA 3\' and reverse VP2 657 XhoI 5\' TCCTCGAGCACTATACGTACCGG 3\' for VP2 and Flag-VP2 in addition to forward VP3 NheI 5\' AGCTAGCATGAACGCTCTCCAAGAAG 3\' and reverse VP3 XhoI 5\' TCCTCGAGCAGTCTTATACACCTTCT 3\' for VP3. The PCR products were then ligated into the yT&A vector (Yeastern Biotech, Taiwan). The *EcoRI*/*XhoI*fragments containing VP2 and Flag-VP2 or *NheI*/*XhoI*fragments containing VP3 were released from the yT&A vector and ligated into pcDNA3.1-GFP, which was a kind gift from Prof. Min-Ying Wang (the Graduate Institute of Biotechnology, National Chung Hsing University, Taichung, Taiwan) and pAcGFP1-N1 (Clontech, USA). The truncated and point mutations of the VP2-GFP constructs were generated in a similar manner to that described above and the primers are summarized in Table [2](#T2){ref-type="table"}. Single site directed and multiple site directed mutagenesis were carried out by PCR using PfuUltra™ High-Fidelity DNA Polymerase (Stratagene, USA) in addition to using pcDNA3.1 VP2-GFP and pcDNA3.1 Flag-VP2-GFP as the template with the primers in Table [2](#T2){ref-type="table"}.

###### 

The primers used to create the various truncated, single and multiple mutants by PCR in this study

  Primer name               Type      Length   Sequence (5\'-3\')
  ------------------------- --------- -------- -----------------------------------------
  VP2 111 N del EcoRI       Forward   26-mer   TGGAATTCATGGAGGACCGATCAACC
                                               
  VP2 141 N del EcoRI       Forward   26-mer   AGGAATTCATGCACTACTCCCAGCCG
                                               
  VP2 160 N del EcoRI       Forward   26-mer   AGGAATTCATGGACGAGCTCGCAGAC
                                               
  VP2 115 C del XhoI        Reverse   24-mer   TCCTCGAGTGATCGGTCCTCAAGT
                                               
  VP2 132 C del XhoI        Reverse   23-mer   TCCTCGAGACCCTGTACTCGGAG
                                               
  VP2 145 C del XhoI        Reverse   26-mer   TCCTCGAGCTGGGAGTAGTGGTAATC
                                               
  VP2 136-138A              Forward   27-mer   AAACGAGCTGCTGCTGCTCTTGATTAC
                                               
  VP2 136-138A              Reverse   27-mer   GTAATCAAGAGCAGCAGCAGCTCGTTT
                                               
  VP2 150-152A              Forward   39-mer   ACCCCGAACGCAGCAGCAGTGTATAAGACTGTAAGATGG
                                               
  VP2 150-152A              Reverse   39-mer   CCATCTTACAGTCTTATACACTGCTGCTGCGTTCGGGGT
                                               
  VP2 136-138A/134/A        Forward   27-mer   GTACAGGGTAAAGCTGCTGCTGCTGCT
                                               
  VP2 136-138A/134/A        Reverse   27-mer   AGCAGCAGCAGCAGCTTTACCCTGTAC
                                               
  VP2 136-138A/133/A        Forward   27-mer   GTACAGGGTGCTCGAGCTGCTGCTGCT
                                               
  VP2 136-138A/133/A        Reverse   27-mer   AGCAGCAGCAGCTCGAGCACCCTGTAC
                                               
  VP2136-138A/133A/134/A    Forward   27-mer   GTACAGGGTGCTGCTGCTGCTGCTGCT
                                               
  VP2 136-138A/133A/134/A   Reverse   27-mer   AGCAGCAGCAGCAGCAGCACCCTGTAC
                                               
  VP2 133A                  Forward   28-mer   GTACAGGGTGCTCGAGCTAAAAGAAAGC
                                               
  VP2 133A                  Reverse   28-mer   GCTTTCTTTTAGCTCGAGCACCCTGTAC
                                               
  VP2 134A                  Forward   28-mer   GTACAGGGTAAAGCTGCTAAAAGAAAGC
                                               
  VP2 134A                  Reverse   28-mer   GCTTTCTTTTAGCAGCTTTACCCTGTAC
                                               
  VP2 133A/134A             Forward   28-mer   GTACAGGGTGCTGCTGCTAAAAGAAAGC
                                               
  VP2 133A/134A             Reverse   28-mer   GCTTTCTTTTAGCAGCAGCACCCTGTAC
                                               
  VP2 C95S                  Forward   20-mer   CGCTAAGATCAGCAACTGCG
                                               
  VP2 C95S                  Reverse   22-mer   CGCAGTTGCTGATCTTAGCGTG
                                               
  VP2 C97S                  Forward   21-mer   ATCTGCAACAGCGGACAATTC
                                               
  VP2 C97S                  Reverse   24-mer   ATTGTCCGCTGTTGCAGATCTTAG
                                               
  VP2 C95S/C97S             Forward   28-mer   CGCTAAGATCAGCAACAGCGGACAATTC
                                               
  VP2 C95S/C97S             Reverse   28-mer   ATTGTCCGCTGTTGCTGATCTTAGCGTG

Amino acid sequence analysis and predication
--------------------------------------------

The amino acid sequences of VP2 from different isolates were identified by searching the UniProtKB database (available at <http://www.uniprot.org/>). The isolates analyzed were Taiwan CIA-89 (in the present paper), Australia/CAU269-7/2000 (accession number: Q9IZU7), Germany Cuxhaven-1(accession number: P69484), Japan 82-2 (accession number: P54093), USA 26p4 (accession number: P54092), and USA CIA-1(accession number: P69485). The amino acid sequences were then aligned and analyzed using program of Biology Workbench 3.2 (San Diego Supercomputer Center; SDSC). The putative NES motif was predicted by the NetNES 1.1 Server \[[@B39]\] while the NLS was predicted by WoLF PSORT \[[@B40]\] and NLStradamus \[[@B41]\].

Cell culture, transfection and staining
---------------------------------------

Chinese hamster ovary (CHO) cells were grown in GIBCO^®^Dulbecco\'s Modified Eagle Medium: Nutrient Mixture F-12 (DMEM/F-12) medium (Invitrogen, USA) supplemented with 10% (v/v) fetal bovine serum (FBS) (GIBCO/Invitrogen, USA), 100 units/ml penicillin, and 100 μg/ml streptomycin. HeLa cells were grown in Dulbecco\'s minimal essential medium (DMEM) (Invitrogen, USA) supplemented with 10% (v/v) FBS, 100 units/ml penicillin, and 100 μg/ml streptomycin. In order to determine the localization of VP2-GFP and the various mutant proteins, pcDNA3.1 VP2-GFP and the various mutant plasmids were transfected into HeLa and CHO cells using TurboFect™ (Fermentas, Canada) by following the manufacturer\'s instructions. The plasmid of pAcGFP-N1 VP3-GFP was also transfected as a positive control for the LMB treatment assay. HeLa or CHO cells were seeded at a density of 2 × 10^4^or 8 × 10^4^cells per well in 24 well culture plates. Forty-eight hours after transfection, aliquots of the cells, underwent replacement with fresh medium containing 20 ng/ml LMB (+) (Calbiochem, Germany) \[[@B27],[@B28]\] or phosphate-buffered saline (PBS) buffer as the LMB (-) control. This was in order to test the nuclear export signals of VP2 and VP3. All cells were fixed using 4% paraformaldehyde solution. After washing three times with 1× PBS, the cells were incubated with 1 × PBS containing 0.25% Triton X-100 for 10 min and stained with 1 μg/ml DAPI (Sigma, USA). GFP fluorescence and DAPI images were captured using a ZEISS AXIOVERT 200 microscope equipped with a 40 objective and an AxioCam HRm CCD camera. Image processing was done using Photoshop. The Alpha View^®^Software (Alpha Innotech Corporation, USA) was used to calculate the distribution of VP2-GFP and mutants across the cytosol and nucleus in the cells.

Cell fractionations
-------------------

Chromatin fractions were prepared by minor modifications of a procedure described previously \[[@B42]\]. After transfection with VP2-GFP plasmid, the CHO cells were lysed in cytoskeleton (CSK) buffer containing 0.5% Triton X-100, 1 mM ATP, 1 mM dithiothreitol, and protease inhibitors (Sigma, USA) for 30 min on ice. The protein extract was then centrifuged at 1500 *g*for 5 min at 4°C. The supernatant was collected and labeled as the soluble fraction (S). The pellet which was chromatin (C) was washed once with CSK buffer for 5 min on ice, then centrifuged at 1500 *g*for 5 min at 4°C, and resuspended in SDS sample buffer. For micrococcal nuclease (MNase) (Fermentas, Canada) or NaCl treatment, the chromatin was resuspended in 100 μl of CSK buffer supplemented with 0.1 M, 0.3 M of NaCl or 0 U (-) and 150 U (+) MNase with 2 mM CaCl~2~and incubated for 30 min at 37°C. After incubation, the chromatin and soluble supernatant were separated by centrifugation. Chromatin and soluble solutions were resuspended and boiled in SDS sample buffer for immunoblotting.

Co-immunoprecipitation
----------------------

After transient transfection with pcDNA 3.1 Flag-VP2-GFP and the various mutants, CHO cells were harvested and lysed using Nonidet P-40 (NP-40) lysis buffer (10 mM HEPES, pH 8.0, 0.2% NP-40, 150 mM NaCl, 1 mM EGTA, 5 mM MgCl~2~and 10% glycerol) containing a cocktail of protease inhibitors (Sigma, USA). After 30 min on ice, the lysates were centrifuged at 13200 rpm for 5 min at 4°C. For co-immunoprecipitation, the 500 μg/ml cell extracts were incubated with 2 μg of anti-Flag M2 beads (Sigma, USA) for 16 h at 4°C. The immunoprecipitate was then washed three times with lysis buffer, resuspended in 20 μl of SDS sample buffer, and the samples were heated for 5 min at 100°C. The soluble proteins were resolved by SDS-PAGE for Western blotting.
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###### Additional file 1

**The effect of LMB treatments on the various mutants of VP2**. The truncated mutants of VP2 in Figure [3A](#F3){ref-type="fig"} were all treated with LMB (+) (20 ng/ml) and LMB (-) (PBS buffer) for 1 h at 37°C. VP3-GFP is LMB sensitive and was used as a positive control. The distribution of GFP was monitored by fluorescence microscopy.

###### 

Click here for file

###### Additional file 2

**Identification of protein-protein interactions with VP2 surveyed by co-immunoprecipitation**. At 48 h post-transfection with plasmids encoding GFP (as the Control) or Flag-VP2-GFP (WT), cell lysates were immunoprecipitated by Flag M2 beads and immunoblotted against VP2, MCM3, CDC7, SMC2, PCNA, and H2B antibodies. The nuclear extracts containing VP2-GFP are designated as N.

###### 

Click here for file

Acknowledgements
================

The authors would like to thank the Prof. Min-Ying Wang (the Graduate Institute of Biotechnology, National Chung Hsing University, Taichung, Taiwan) for kindly providing the pcDNA3.1-GFP plasmid. This research was supported by grants from the National Science Council (Grant nos. NSC-95-2313-B-039-004-; NSC-96-2313-B-276-001-MY3), China Medical University (CMU100-TS-05) as well as CMRPG860542 and CZRPG860563.
